|
|
||||||||






* Department of Bioengineering, Tokyo Institute of Technology, Yokohama, Japan;
Department of Biochemistry, School of Dentistry, Showa University, Tokyo, Japan;
Department of Biochemistry, School of Dentistry, and
Institute for Oral Science, Matsumoto Dental University, Shiojiri, Japan; and
¶ Department of Biological Chemistry, Chubu University, Kasugai, Japan
LPS is a potent stimulator of bone resorption in inflammatory diseases. The mechanism by which LPS induces osteoclastogenesis was studied in cocultures of mouse osteoblasts and bone marrow cells. LPS stimulated osteoclast formation and PGE2 production in cocultures of mouse osteoblasts and bone marrow cells, and the stimulation was completely inhibited by NS398, a cyclooxygenase-2 inhibitor. Osteoblasts, but not bone marrow cells, produced PGE2 in response to LPS. LPS-induced osteoclast formation was also inhibited by osteoprotegerin (OPG), a decoy receptor of receptor activator of NF-
B ligand (RANKL), but not by anti-mouse TNFR1 Ab or IL-1 receptor antagonist. LPS induced both stimulation of RANKL mRNA expression and inhibition of OPG mRNA expression in osteoblasts. NS398 blocked LPS-induced down-regulation of OPG mRNA expression, but not LPS-induced up-regulation of RANKL mRNA expression, suggesting that down-regulation of OPG expression by PGE2 is involved in LPS-induced osteoclast formation in the cocultures. NS398 failed to inhibit LPS-induced osteoclastogenesis in cocultures containing OPG knockout mouse-derived osteoblasts. IL-1 also stimulated PGE2 production in osteoblasts and osteoclast formation in the cocultures, and the stimulation was inhibited by NS398. As seen with LPS, NS398 failed to inhibit IL-1-induced osteoclast formation in cocultures with OPG-deficient osteoblasts. These results suggest that IL-1 as well as LPS stimulates osteoclastogenesis through two parallel events: direct enhancement of RANKL expression and suppression of OPG expression, which is mediated by PGE2 production.
This article has been cited by other articles:
![]() |
S. N. Somayaji, S. Ritchie, M. Sahraei, I. Marriott, and M. C. Hudson Staphylococcus aureus Induces Expression of Receptor Activator of NF-{kappa}B Ligand and Prostaglandin E2 in Infected Murine Osteoblasts Infect. Immun., November 1, 2008; 76(11): 5120 - 5126. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Oka, M. Miyauchi, K. Sakamoto, S. Moriwaki, S. Niida, K. Noguchi, M.J. Somerman, and T. Takata PGE2 Activates Cementoclastogenesis by Cementoblasts via EP4 Journal of Dental Research, October 1, 2007; 86(10): 974 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Mrak, I Villa, R Lanzi, M Losa, F Guidobono, and A Rubinacci Growth hormone stimulates osteoprotegerin expression and secretion in human osteoblast-like cells J. Endocrinol., March 1, 2007; 192(3): 639 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Villa, E. Mrak, A. Rubinacci, F. Ravasi, and F. Guidobono CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway Am J Physiol Cell Physiol, September 1, 2006; 291(3): C529 - C537. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nemoto, R.P. Darveau, B.L. Foster, G.R. Nogueira-Filho, and M.J. Somerman Regulation of Cementoblast Function by P. gingivalis Lipopolysaccharide via TLR2 Journal of Dental Research, August 1, 2006; 85(8): 733 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ha, J.-H. Lee, H.-N. Kim, H.-M. Kim, H. B. Kwak, S. Lee, H.-H. Kim, and Z. H. Lee {alpha}-Lipoic Acid Inhibits Inflammatory Bone Resorption by Suppressing Prostaglandin E2 Synthesis J. Immunol., January 1, 2006; 176(1): 111 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, S. Takeyama, T. Kikuchi, S. Yamada, J. Sodek, and H. Shinoda Osteoclast Responses to Lipopolysaccharide, Parathyroid Hormone and Bisphosphonates in Neonatal Murine Calvaria Analyzed by Laser Scanning Confocal Microscopy J. Histochem. Cytochem., December 1, 2005; 53(12): 1525 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Frick, K. LaPlante, and D. A. Bushinsky RANK ligand and TNF-{alpha} mediate acid-induced bone calcium efflux in vitro Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1005 - F1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yang, N. Takahashi, T. Yamashita, N. Sato, M. Takahashi, M. Mogi, T. Uematsu, Y. Kobayashi, Y. Nakamichi, K. Takeda, et al. Muramyl Dipeptide Enhances Osteoclast Formation Induced by Lipopolysaccharide, IL-1{alpha}, and TNF-{alpha} through Nucleotide-Binding Oligomerization Domain 2-Mediated Signaling in Osteoblasts J. Immunol., August 1, 2005; 175(3): 1956 - 1964. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kobayashi, I. Take, T. Yamashita, T. Mizoguchi, T. Ninomiya, T. Hattori, S. Kurihara, H. Ozawa, N. Udagawa, and N. Takahashi Prostaglandin E2 Receptors EP2 and EP4 Are Down-regulated during Differentiation of Mouse Osteoclasts from Their Precursors J. Biol. Chem., June 24, 2005; 280(25): 24035 - 24042. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kobayashi, T. Mizoguchi, I. Take, S. Kurihara, N. Udagawa, and N. Takahashi Prostaglandin E2 Enhances Osteoclastic Differentiation of Precursor Cells through Protein Kinase A-dependent Phosphorylation of TAK1 J. Biol. Chem., March 25, 2005; 280(12): 11395 - 11403. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sato, N. Takahashi, K. Suda, M. Nakamura, M. Yamaki, T. Ninomiya, Y. Kobayashi, H. Takada, K. Shibata, M. Yamamoto, et al. MyD88 But Not TRIF Is Essential for Osteoclastogenesis Induced by Lipopolysaccharide, Diacyl Lipopeptide, and IL-1{alpha} J. Exp. Med., September 7, 2004; 200(5): 601 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kamei, K. Yamakawa, Y. Takegoshi, M. Mikami-Nakanishi, Y. Nakatani, S. Oh-ishi, H. Yasui, Y. Azuma, N. Hirasawa, K. Ohuchi, et al. Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1 J. Biol. Chem., August 6, 2004; 279(32): 33684 - 33695. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |